Global Defibrillators Market
Defibrillators Market Overview
The global defibrillators market is expected to reach $18,469 million by 2025, growing ata a CAGR of 6.2% during 2017-2025. Defibrillators are devices used to deliver therapeutic shock to a patients heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations has fueled the market growth. Moreover, advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases among all ages are further driving the market growth. However, product failures and recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.
The global defibrillators market is segmented on the basis of product, end-user, and geography. Implantable cardioverter-defibrillator (ICDs) and external defibrillators are two major product categories of defibrillators. ICDs are further categorized into cardiac resynchronization therapy - defibrillator (CRT-D), trans venous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). The T-ICDs market is the largest within Implantable cardioverter-defibrillator market owing to higher precision and targeted functioning.
In addition, external defibrillators are further categorized into manual external defibrillator (MEDs), automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs). AEDs are most commonly used external defibrillator accounting for more than two-thirds of external defibrillator market revenue in 2015. However, WCDs are gaining express momentum and is expected to churn substantial revenue share of both MEDs and AEDs during forecast period due its easy to use and wearable features.
AED is the preferred external defibrillation system:
External defibrillators are life-saving medical devices used to deliver defibrillating shock through paddles or electrode pads to diagnose and restore life-threatening abnormal heart rhythms in the conditions of unexpected cardiac arrest. These devices are capable of performing cardioversion, defibrillation, and pacing of the heart. External defibrillators are the three major types, namely manual external defibrillator, AEDs and WCDs. AEDs are used in most cases among SCA patients due to productive opportunities observed and ease in use, thereby bagging a large market share in the defibrillators market.
The increasing adoption of technologically advanced defibrillators, growing demand for quality medical care, high incidences of SCA and cardiovascular diseases are the drivers of the defibrillators market. In addition, the increasing focus of public & private organizations and key market players on public access defibrillators; and increasing number of training & awareness programs across the globe are few more factors driving the growth of the global defibrillators market. Moreover, promoting the innovation of the next-generation external defibrillators to improve safety and effectiveness, enhancing the ability of industry, identifying and addressing problems associated with devices by the FDA, and focusing on the SCA are anticipated to create lucrative opportunities for the defibrillators market worldwide. SCA is the leading cause of death globally, which is a life-threatening condition. It can be treated successfully by early intervention of the disease with defibrillation at the right time. The global external defibrillators market is dominated by automated external defibrillators (AEDs) and expected to grow with highest rate in future due to increase in adoption by heart failure patients across the globe. The increasing installations of public access AEDs, growing incidence of cardiovascular diseases, and growing awareness regarding the lifesaving potential of AEDs have fueled the market growth. The second largest market of external defibrillators is covered by manual external defibrillators followed by wearable external defibrillators.
Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases: throttling the market growth
SCA is a sudden and unexpected pulseless condition, which is caused by the cessation of cardiac mechanical activity. SCA is a leading cause of death among adults, usually above the age of 40. In the U.S. alone, 326,200 people experienced out-of-hospital cardiac arrests (OHCA) in 2011. In addition, cardiac diseases are the leading cause of death worldwide, accounting for 17.3 million deaths per year and projected to grow more than 23.6 million by 2030. According to the American Heart Association, 5.5 million people are affected by heart failure in the U.S. alone, while 10 million in European countries. Furthermore, in the U.S., around 700,000 new cases of heart failure are diagnosed annually and approximately 58,000 patient deaths are attributed to heart failure annually. This is one of the major driving factors for the growth of the defibrillators market. Moreover, the rising incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to lifestyle habits such as unhealthy dietary habits, lack of physical activity and smoking, among others, is the leading cause of CHF. Moreover, rising geriatric population base is expected to fuel the prevalence of CHFs, thereby augmenting the market growth.
Asia Pacific: Most Lucrative Defibrillators Market
The Asia-Pacific region includes China, Japan, India, Australia, Malaysia, Thailand, New Zealand, and other countries in the Pacific Rim. The Asia-Pacific region offers lucrative opportunities in the defibrillators market, anticipated to be the fastest-growing market during the forecast period. Asia-Pacifc is densely populated with India and China being the most populous. Its growth is supplemented by the growing demand for sophisticated defibrillators, large number of healthcare reforms, high prevalence of heart failures, and increased focus of key players on developing technologically advanced cost-effective defibrillators.
However, the weak reimbursement scenario for defibrillation procedures, lack in advanced healthcare infrastructure, low awareness among physicians & patients about different treatment devices, and high cost of these devices are impeding the growth of the defibrillators market in these countries.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
KEY BENEFITS OF THE REPORT
By Product
The global defibrillators market is expected to reach $18,469 million by 2025, growing ata a CAGR of 6.2% during 2017-2025. Defibrillators are devices used to deliver therapeutic shock to a patients heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations has fueled the market growth. Moreover, advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases among all ages are further driving the market growth. However, product failures and recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.
The global defibrillators market is segmented on the basis of product, end-user, and geography. Implantable cardioverter-defibrillator (ICDs) and external defibrillators are two major product categories of defibrillators. ICDs are further categorized into cardiac resynchronization therapy - defibrillator (CRT-D), trans venous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). The T-ICDs market is the largest within Implantable cardioverter-defibrillator market owing to higher precision and targeted functioning.
In addition, external defibrillators are further categorized into manual external defibrillator (MEDs), automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs). AEDs are most commonly used external defibrillator accounting for more than two-thirds of external defibrillator market revenue in 2015. However, WCDs are gaining express momentum and is expected to churn substantial revenue share of both MEDs and AEDs during forecast period due its easy to use and wearable features.
AED is the preferred external defibrillation system:
External defibrillators are life-saving medical devices used to deliver defibrillating shock through paddles or electrode pads to diagnose and restore life-threatening abnormal heart rhythms in the conditions of unexpected cardiac arrest. These devices are capable of performing cardioversion, defibrillation, and pacing of the heart. External defibrillators are the three major types, namely manual external defibrillator, AEDs and WCDs. AEDs are used in most cases among SCA patients due to productive opportunities observed and ease in use, thereby bagging a large market share in the defibrillators market.
The increasing adoption of technologically advanced defibrillators, growing demand for quality medical care, high incidences of SCA and cardiovascular diseases are the drivers of the defibrillators market. In addition, the increasing focus of public & private organizations and key market players on public access defibrillators; and increasing number of training & awareness programs across the globe are few more factors driving the growth of the global defibrillators market. Moreover, promoting the innovation of the next-generation external defibrillators to improve safety and effectiveness, enhancing the ability of industry, identifying and addressing problems associated with devices by the FDA, and focusing on the SCA are anticipated to create lucrative opportunities for the defibrillators market worldwide. SCA is the leading cause of death globally, which is a life-threatening condition. It can be treated successfully by early intervention of the disease with defibrillation at the right time. The global external defibrillators market is dominated by automated external defibrillators (AEDs) and expected to grow with highest rate in future due to increase in adoption by heart failure patients across the globe. The increasing installations of public access AEDs, growing incidence of cardiovascular diseases, and growing awareness regarding the lifesaving potential of AEDs have fueled the market growth. The second largest market of external defibrillators is covered by manual external defibrillators followed by wearable external defibrillators.
Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases: throttling the market growth
SCA is a sudden and unexpected pulseless condition, which is caused by the cessation of cardiac mechanical activity. SCA is a leading cause of death among adults, usually above the age of 40. In the U.S. alone, 326,200 people experienced out-of-hospital cardiac arrests (OHCA) in 2011. In addition, cardiac diseases are the leading cause of death worldwide, accounting for 17.3 million deaths per year and projected to grow more than 23.6 million by 2030. According to the American Heart Association, 5.5 million people are affected by heart failure in the U.S. alone, while 10 million in European countries. Furthermore, in the U.S., around 700,000 new cases of heart failure are diagnosed annually and approximately 58,000 patient deaths are attributed to heart failure annually. This is one of the major driving factors for the growth of the defibrillators market. Moreover, the rising incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to lifestyle habits such as unhealthy dietary habits, lack of physical activity and smoking, among others, is the leading cause of CHF. Moreover, rising geriatric population base is expected to fuel the prevalence of CHFs, thereby augmenting the market growth.
Asia Pacific: Most Lucrative Defibrillators Market
The Asia-Pacific region includes China, Japan, India, Australia, Malaysia, Thailand, New Zealand, and other countries in the Pacific Rim. The Asia-Pacific region offers lucrative opportunities in the defibrillators market, anticipated to be the fastest-growing market during the forecast period. Asia-Pacifc is densely populated with India and China being the most populous. Its growth is supplemented by the growing demand for sophisticated defibrillators, large number of healthcare reforms, high prevalence of heart failures, and increased focus of key players on developing technologically advanced cost-effective defibrillators.
However, the weak reimbursement scenario for defibrillation procedures, lack in advanced healthcare infrastructure, low awareness among physicians & patients about different treatment devices, and high cost of these devices are impeding the growth of the defibrillators market in these countries.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
KEY BENEFITS OF THE REPORT
- The study provides an in-depth analysis of the world defibrillation market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2016 to 2025, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.
- Competitive intelligence highlights the business practices followed by leading players across various regions.
- SWOT analysis studies the internal environment of the leading companies for strategy formulation.
By Product
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs),
- Wearable Cardioverter Defibrillator (WCDs).
- Hospitals
- Prehospital
- Public Access market
- Alternate Care Market
- Home
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Egypt
- Israel
- South Africa
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies
3.3 Porters Five Forces Analysis
3.3.1 High competition and fragmented market moderate the power of the suppliers
3.3.2 Scattered and large number of buyers moderate their bargaining power
3.3.3 High capital investment moderates the threat of new entrants
3.3.4 High intensity of rivalry
3.3.5 Unavailability of substitutes lowers the threat of substitutes
3.4 Market Share Analysis, 2015
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases across the globe
3.5.1.2 Technological advancements in defibrillators
3.5.1.3 Increasing patient awareness
3.5.1.4 High presence of unmet medical needs
3.5.2 Restraints
3.5.2.1 Limited insurance coverage and high cost of the defibrillators
3.5.2.2 preference of drugs over defibrillators
3.5.3 Opportunities
3.5.3.1 Lucrative opportunities in emerging economies
3.5.3.2 Development of new MRI-labeled devices
CHAPTER 4 WORLD DEFRIBILLATORS MARKET, BY PRODUCT
4.1 Overview
4.2 Implantable Cardioverter Defibrillators (ICDs)
4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.3.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
4.2.3.1.1 Market Size and Forecast
4.2.3.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
4.2.3.2.1 Market Size and Forecast
4.2.3.3 CRT with pacemaker and ICD function (CRT-D)
4.2.3.3.1 Market Size and Forecast
4.3 External Defibrillator
4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast
4.3.4 Manual External Defibrillator
4.3.4.1 Market size and forecast
4.3.5 Automated External Defibrillator (AEDs)
4.3.5.1 Market size and forecast
4.3.5.2 Semi-automated EXTERNAL DEFIBRILLATOR
4.3.5.2.1 Market Size and Forecast
4.3.5.3 Fully automated External Defibrillator
4.3.5.3.1 Market Size and Forecast
4.3.6 Wearable Cardioverter Defibrillator (WCDs)
4.3.6.1 Market size and forecast
CHAPTER 5 WORLD DEFRIBILLATORS MARKET, BY END USER
5.1 Overview
5.1.1 Market Size and Forecast
5.2 Hospitals
5.2.1 Market Size and Forecast
5.3 Prehospital
5.3.1 Market Size and Forecast
5.4 Public Access Market
5.4.1 Market Size and Forecast
5.5 Alternate Care Market
5.5.1 Market Size and Forecast
5.6 Home
5.6.1 Market Size and Forecast
CHAPTER 6 DEFIBRILLATORS MARKET, BY GEOGRAPHY, 2015-2022
6.1 Overview
6.1.1 Market Size and Forecast
6.2 North America
6.2.1 Key Market Trends
6.2.2 Key Growth Factors and Opportunities
6.2.3 Market Size and Forecast
6.2.3.1 U.S. Market size and forecast
6.2.3.2 Canada Market size and forecast
6.2.3.3 Mexico Market size and forecast
6.3 Europe
6.3.1 Key Market Trends
6.3.2 Key Growth Factors and Opportunities
6.3.3 Market Size and Forecast
6.3.3.1 U.K. Market size and forecast
6.3.3.2 France Market size and forecast
6.3.3.3 Germany Market size and forecast
6.3.3.4 Italy Market size and forecast
6.3.3.5 Spain Market size and forecast
6.3.3.6 Rest of Europe Market size and forecast
6.4 Asia-Pacific
6.4.1 Key Market Trends
6.4.2 Key Growth Factors and Opportunities
6.4.3 Market Size and Forecast
6.4.3.1 Japan Market size and forecast
6.4.3.2 China Market size and forecast
6.4.3.3 India Market size and forecast
6.4.3.4 Australia Market size and forecast
6.4.3.5 Rest of Asia-Pacific Market size and forecast
6.5 LAMEA
6.5.1 Key Market Trends
6.5.2 Key Growth Factors and Opportunities
6.5.3 Market Size and Forecast
6.5.3.1 Brazil Market size and forecast
6.5.3.2 Argentina Market size and forecast
6.5.3.3 Egypt Market size and forecast
6.5.3.4 Israel Market size and forecast
6.5.3.5 South Africa Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Asahi Kasei Corporation
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Business Performance
7.1.5 Key Strategic Moves and Developments
7.1.6 SWOT Analysis
7.2 Stryker Corporation
7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating Business Segments
7.2.4 Business Performance
7.2.5 Key Strategic Moves and Development
7.2.6 SWOT Analysis
7.3 Biotronik SE & Co. KG
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating Business Segments
7.3.4 Key Strategic Moves & Developments
7.3.5 SWOT Analysis
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating Business Segments
7.4.4 Business Performance
7.4.5 Key Strategic Moves and Developments
7.4.6 SWOT Analysis
7.5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments Overview
7.5.4 Business Performance
7.5.5 SWOT Analysis
7.6 LivaNova PLC
7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments
7.6.4 Business Performance
7.6.5 Key Strategic Moves and Developments
7.6.6 SWOT Analysis
7.7 Medtronic PLC
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating Business Segments
7.7.4 Business Performance
7.7.5 Key Strategic Moves and Developments
7.7.6 SWOT Analysis
7.8 St. Jude Medical, Inc.
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating Business Segments
7.8.4 Business Performance
7.8.5 Key Strategic Moves and Developments
7.8.6 SWOT Analysis
7.9 Cardiac Science Corporation
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating Business Segments
7.9.4 Key Strategic Moves and Developments
7.9.5 SWOT Analysis
7.10 Nihon Koden Corporation
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating Business Segments
7.10.4 Business Performance
7.10.5 Key Strategic Moves and Developments
7.10.6 SWOT Analysis
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies
3.3 Porters Five Forces Analysis
3.3.1 High competition and fragmented market moderate the power of the suppliers
3.3.2 Scattered and large number of buyers moderate their bargaining power
3.3.3 High capital investment moderates the threat of new entrants
3.3.4 High intensity of rivalry
3.3.5 Unavailability of substitutes lowers the threat of substitutes
3.4 Market Share Analysis, 2015
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases across the globe
3.5.1.2 Technological advancements in defibrillators
3.5.1.3 Increasing patient awareness
3.5.1.4 High presence of unmet medical needs
3.5.2 Restraints
3.5.2.1 Limited insurance coverage and high cost of the defibrillators
3.5.2.2 preference of drugs over defibrillators
3.5.3 Opportunities
3.5.3.1 Lucrative opportunities in emerging economies
3.5.3.2 Development of new MRI-labeled devices
CHAPTER 4 WORLD DEFRIBILLATORS MARKET, BY PRODUCT
4.1 Overview
4.2 Implantable Cardioverter Defibrillators (ICDs)
4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.3.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
4.2.3.1.1 Market Size and Forecast
4.2.3.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
4.2.3.2.1 Market Size and Forecast
4.2.3.3 CRT with pacemaker and ICD function (CRT-D)
4.2.3.3.1 Market Size and Forecast
4.3 External Defibrillator
4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast
4.3.4 Manual External Defibrillator
4.3.4.1 Market size and forecast
4.3.5 Automated External Defibrillator (AEDs)
4.3.5.1 Market size and forecast
4.3.5.2 Semi-automated EXTERNAL DEFIBRILLATOR
4.3.5.2.1 Market Size and Forecast
4.3.5.3 Fully automated External Defibrillator
4.3.5.3.1 Market Size and Forecast
4.3.6 Wearable Cardioverter Defibrillator (WCDs)
4.3.6.1 Market size and forecast
CHAPTER 5 WORLD DEFRIBILLATORS MARKET, BY END USER
5.1 Overview
5.1.1 Market Size and Forecast
5.2 Hospitals
5.2.1 Market Size and Forecast
5.3 Prehospital
5.3.1 Market Size and Forecast
5.4 Public Access Market
5.4.1 Market Size and Forecast
5.5 Alternate Care Market
5.5.1 Market Size and Forecast
5.6 Home
5.6.1 Market Size and Forecast
CHAPTER 6 DEFIBRILLATORS MARKET, BY GEOGRAPHY, 2015-2022
6.1 Overview
6.1.1 Market Size and Forecast
6.2 North America
6.2.1 Key Market Trends
6.2.2 Key Growth Factors and Opportunities
6.2.3 Market Size and Forecast
6.2.3.1 U.S. Market size and forecast
6.2.3.2 Canada Market size and forecast
6.2.3.3 Mexico Market size and forecast
6.3 Europe
6.3.1 Key Market Trends
6.3.2 Key Growth Factors and Opportunities
6.3.3 Market Size and Forecast
6.3.3.1 U.K. Market size and forecast
6.3.3.2 France Market size and forecast
6.3.3.3 Germany Market size and forecast
6.3.3.4 Italy Market size and forecast
6.3.3.5 Spain Market size and forecast
6.3.3.6 Rest of Europe Market size and forecast
6.4 Asia-Pacific
6.4.1 Key Market Trends
6.4.2 Key Growth Factors and Opportunities
6.4.3 Market Size and Forecast
6.4.3.1 Japan Market size and forecast
6.4.3.2 China Market size and forecast
6.4.3.3 India Market size and forecast
6.4.3.4 Australia Market size and forecast
6.4.3.5 Rest of Asia-Pacific Market size and forecast
6.5 LAMEA
6.5.1 Key Market Trends
6.5.2 Key Growth Factors and Opportunities
6.5.3 Market Size and Forecast
6.5.3.1 Brazil Market size and forecast
6.5.3.2 Argentina Market size and forecast
6.5.3.3 Egypt Market size and forecast
6.5.3.4 Israel Market size and forecast
6.5.3.5 South Africa Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Asahi Kasei Corporation
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Business Performance
7.1.5 Key Strategic Moves and Developments
7.1.6 SWOT Analysis
7.2 Stryker Corporation
7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating Business Segments
7.2.4 Business Performance
7.2.5 Key Strategic Moves and Development
7.2.6 SWOT Analysis
7.3 Biotronik SE & Co. KG
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating Business Segments
7.3.4 Key Strategic Moves & Developments
7.3.5 SWOT Analysis
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating Business Segments
7.4.4 Business Performance
7.4.5 Key Strategic Moves and Developments
7.4.6 SWOT Analysis
7.5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments Overview
7.5.4 Business Performance
7.5.5 SWOT Analysis
7.6 LivaNova PLC
7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments
7.6.4 Business Performance
7.6.5 Key Strategic Moves and Developments
7.6.6 SWOT Analysis
7.7 Medtronic PLC
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating Business Segments
7.7.4 Business Performance
7.7.5 Key Strategic Moves and Developments
7.7.6 SWOT Analysis
7.8 St. Jude Medical, Inc.
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating Business Segments
7.8.4 Business Performance
7.8.5 Key Strategic Moves and Developments
7.8.6 SWOT Analysis
7.9 Cardiac Science Corporation
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating Business Segments
7.9.4 Key Strategic Moves and Developments
7.9.5 SWOT Analysis
7.10 Nihon Koden Corporation
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating Business Segments
7.10.4 Business Performance
7.10.5 Key Strategic Moves and Developments
7.10.6 SWOT Analysis
LIST OF TABLES
Table 1 WORLD DEFIBRILLATOR MARKET, BY PRODUCT TYPE, VOLUME, 20142022 (UNIT)
Table 2 WORLD DEFIBRILLATOR MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 3 WORLD ICDS MARKET, BY TYPE, VOLUME, 20142022 (UNIT)
Table 4 WORLD ICDS MARKET, BY TYPE, 20142022 ($MILLION)
Table 5 WORLD ICDS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
Table 6 WORLD EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, VOLUME, 20142022 (UNIT)
Table 7 WORLD EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 20142022 ($MILLION)
Table 8 EXTERNAL DEFIBRILLATORS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
Table 9 WORLD AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) MARKET, BY TYPE, 20152022 ($MILLION)
Table 10 WORLD DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 11 WORLD DEFIBRILLATORS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
Table 12 WORLD DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 13 WORLD: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 14 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 15 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 16 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 17 NORTH AMERICA: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 18 NORTH AMERICA: EXTERNAL DEFIBRILLATOR MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 19 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 20 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 21 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 22 EUROPE: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 23 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 24 ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 25 ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 26 ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 27 ASIA-PACIFIC: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 28 ASIA-PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 29 LAMEA: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 30 LAMEA: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 31 LAMEA: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 32 LAMEA: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 33 LAMEA: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 34 ZOLL MEDICAL CORPORATION: COMPANY SNAPSHOT
Table 35 STRYKER CORPORATION: COMPANY SNAPSHOT
Table 36 BIOTRONIK: COMPANY SNAPSHOT
Table 37 BIOTRONIK: OPERATING SEGMENTS
Table 38 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
Table 39 BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
Table 40 PHILIPS HEALTHCARE: SNAPSHOT
Table 41 Table 2 PHILIPS: OPERATING SEGMENTS
Table 42 LIVANOVA: COMPANY SNAPSHOT
Table 43 LIVANOVA: OPERATING SEGMENTS
Table 44 MEDTRONIC: COMPANY SNAPSHOT
Table 45 MEDTRONIC: OPERATING SEGMENTS
Table 46 ST. JUDE MEDICAL: COMPANY SNAPSHOT
Table 47 ST. JUDE MEDICAL: PRODUCT CATEGORIES
Table 48 CARDIAC SCIENCE CORPORATION: COMPANY SNAPSHOT
Table 49 CARDIAC SCIENCE CORPORATION: OPERATING SEGMENTS
Table 50 NIHON KOHDEN: COMPANY SNAPSHOT
Table 51 NIHON KOHDEN: OPERATING SEGMENTS
Table 1 WORLD DEFIBRILLATOR MARKET, BY PRODUCT TYPE, VOLUME, 20142022 (UNIT)
Table 2 WORLD DEFIBRILLATOR MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 3 WORLD ICDS MARKET, BY TYPE, VOLUME, 20142022 (UNIT)
Table 4 WORLD ICDS MARKET, BY TYPE, 20142022 ($MILLION)
Table 5 WORLD ICDS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
Table 6 WORLD EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, VOLUME, 20142022 (UNIT)
Table 7 WORLD EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 20142022 ($MILLION)
Table 8 EXTERNAL DEFIBRILLATORS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
Table 9 WORLD AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) MARKET, BY TYPE, 20152022 ($MILLION)
Table 10 WORLD DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 11 WORLD DEFIBRILLATORS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
Table 12 WORLD DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 13 WORLD: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 14 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 15 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 16 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 17 NORTH AMERICA: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 18 NORTH AMERICA: EXTERNAL DEFIBRILLATOR MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 19 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 20 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 21 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 22 EUROPE: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 23 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 24 ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 25 ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 26 ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 27 ASIA-PACIFIC: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 28 ASIA-PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 29 LAMEA: DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 30 LAMEA: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
Table 31 LAMEA: DEFIBRILLATORS MARKET, BY END USER, 20142022 ($MILLION)
Table 32 LAMEA: ICDS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 33 LAMEA: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 20142022 ($MILLION)
Table 34 ZOLL MEDICAL CORPORATION: COMPANY SNAPSHOT
Table 35 STRYKER CORPORATION: COMPANY SNAPSHOT
Table 36 BIOTRONIK: COMPANY SNAPSHOT
Table 37 BIOTRONIK: OPERATING SEGMENTS
Table 38 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
Table 39 BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
Table 40 PHILIPS HEALTHCARE: SNAPSHOT
Table 41 Table 2 PHILIPS: OPERATING SEGMENTS
Table 42 LIVANOVA: COMPANY SNAPSHOT
Table 43 LIVANOVA: OPERATING SEGMENTS
Table 44 MEDTRONIC: COMPANY SNAPSHOT
Table 45 MEDTRONIC: OPERATING SEGMENTS
Table 46 ST. JUDE MEDICAL: COMPANY SNAPSHOT
Table 47 ST. JUDE MEDICAL: PRODUCT CATEGORIES
Table 48 CARDIAC SCIENCE CORPORATION: COMPANY SNAPSHOT
Table 49 CARDIAC SCIENCE CORPORATION: OPERATING SEGMENTS
Table 50 NIHON KOHDEN: COMPANY SNAPSHOT
Table 51 NIHON KOHDEN: OPERATING SEGMENTS
LIST OF FIGURES
Fig. 1 TOP INVESTMENT POCKETS IN WORLD DEFIBRILLATORS MARKET
Fig. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20142016
Fig. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
Fig. 4 PORTERS FIVE FORCES ANALYSIS
Fig. 5 MARKET SHARE ANALYSIS, 2015
Fig. 6 TOP IMPACTING FACTORS: WORLD DEFIBRILLATORS MARKET
Fig. 7 WORLD TRANSVENOUS IMPLANTable CARDIOVERTER DEFIBRILLATOR (T-ICDS) MARKET, 20142022 ($MILLION)
Fig. 8 WORLD SUBCUTANEOUS IMPLANTable CARDIOVERTER DEFIBRILLATOR (S-ICDS) MARKET, 20142022 ($MILLION)
Fig. 9 WORLD CRT-D DEFRIBILLATORS MARKET, 20142022 ($MILLION)
Fig. 10 WORLD MANUAL EXTERNAL DEFIBRILLATOR MARKET, 20142022 ($MILLION)
Fig. 11 WORLD SEMI-AUTOMATED EXTERNAL DEFIBRILLATOR (AED) MARKET, 20142022 ($MILLION)
Fig. 12 WORLD FULLY-AUTOMATED DEFIBRILLATOR MARKET, 20142022 ($MILLION)
Fig. 13 WORLD WEARABLE EXTERNAL DEFIBRILLATOR MARKET, 20142022 ($MILLION)
Fig. 14 WORLD DEFIBRILLATORS MARKET FOR HOSPITALS, 20142022 ($MILLION)
Fig. 15 WORLD DEFIBRILLATORS MARKET FOR PREHOSPITAL, 20142022 ($MILLION)
Fig. 16 WORLD DEFIBRILLATORS MARKET FOR PUBLIC ACCESS DEFIBRILLATION, 20142022 ($MILLION)
Fig. 17 WORLD DEFIBRILLATORS MARKET FOR ALTERNATE CARE MARKET, 20142022 ($MILLION)
Fig. 18 WORLD DEFIBRILLATORS MARKET FOR HOME, 20142022 ($MILLION)
Fig. 19 U.S. DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 20 CANADA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 21 MEXICO DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 22 U.K. DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 23 FRANCE DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 24 GERMANY DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 25 ITALY DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 26 SPAIN DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 27 REST OF EUROPE DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 28 JAPAN DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 29 CHINA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 30 INDIA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 31 AUSTRALIA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 32 REST OF ASIA-PACIFIC DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 33 BRAZIL DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 34 ARGENTINA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 35 EGYPT DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 36 ISRAEL DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 37 SOUTH AFRICA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 38 ASAHI KASEI CORPORATION: NET REVENUE, 20122014($MILLION)
Fig. 39 ASAHI KASEI CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
Fig. 40 ASAHI KASEI CORPORATION: HEALTHCARE GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 41 ASAHI KASEI CORPORATION: SWOT ANALYSIS
Fig. 42 STRYKER CORPORATION: NET SALES, 20132015 ($MILLION)
Fig. 43 STRYKER CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
Fig. 44 STRYKER CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 45 STRYKER CORPORATION: SWOT ANALYSIS
Fig. 46 BIOTRONIK: SWOT ANALYSIS
Fig. 47 BOSTON SCIENTIFIC CORPORATION: NET SALES, 20132015, ($MILLION)
Fig. 48 BOSTON SCIENTIFIC CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 49 BOSTON SCIENTIFIC CORPORATION: RHYTHM MANAGEMENT REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 50 BOSTON SCIENTIFIC CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 51 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
Fig. 52 PHILIPS: REVENUE, 20132015 ($MILLION)
Fig. 53 PHILIPS: REVENUE, BY SEGMENTS, 2015 (%)
Fig. 54 PHILIPS: HEALTHCARE REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 55 PHILIPS: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 56 PHILIPS HEALTHCARE: SWOT ANALYSIS
Fig. 57 LIVANOVA: NET SALES, 20132015 ($MILLION)
Fig. 58 LIVANOVA: REVENUE, BY BUSINESS SEGMENTS, 2015 (%)
Fig. 59 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 60 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 61 LIVANOVA: SWOT ANALYSIS
Fig. 62 MEDTRONIC: NET SALES, 20132015 ($MILLION)
Fig. 63 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
Fig. 64 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 65 MEDTRONIC: SWOT ANALYSIS
Fig. 66 ST. JUDE MEDICAL: NET SALES, 20132015 ($MILLION)
Fig. 67 ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
Fig. 68 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 69 ST. JUDE MEDICAL: SWOT ANALYSIS
Fig. 70 CARDIAC SCIENCE CORPORATION: SWOT ANALYSIS
Fig. 71 NIHON KODEN: REVENUE, 20132015($MILLION)
Fig. 72 NIHON KODEN: REVENUE, BY SEGMENTS, 2015(%)
Fig. 73 NIHON KODEN: REVENUE, BY GEOGRAPHY, 2015(%)
Fig. 74 NIHON KOHDEN: SWOT ANALYSIS
Fig. 1 TOP INVESTMENT POCKETS IN WORLD DEFIBRILLATORS MARKET
Fig. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20142016
Fig. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
Fig. 4 PORTERS FIVE FORCES ANALYSIS
Fig. 5 MARKET SHARE ANALYSIS, 2015
Fig. 6 TOP IMPACTING FACTORS: WORLD DEFIBRILLATORS MARKET
Fig. 7 WORLD TRANSVENOUS IMPLANTable CARDIOVERTER DEFIBRILLATOR (T-ICDS) MARKET, 20142022 ($MILLION)
Fig. 8 WORLD SUBCUTANEOUS IMPLANTable CARDIOVERTER DEFIBRILLATOR (S-ICDS) MARKET, 20142022 ($MILLION)
Fig. 9 WORLD CRT-D DEFRIBILLATORS MARKET, 20142022 ($MILLION)
Fig. 10 WORLD MANUAL EXTERNAL DEFIBRILLATOR MARKET, 20142022 ($MILLION)
Fig. 11 WORLD SEMI-AUTOMATED EXTERNAL DEFIBRILLATOR (AED) MARKET, 20142022 ($MILLION)
Fig. 12 WORLD FULLY-AUTOMATED DEFIBRILLATOR MARKET, 20142022 ($MILLION)
Fig. 13 WORLD WEARABLE EXTERNAL DEFIBRILLATOR MARKET, 20142022 ($MILLION)
Fig. 14 WORLD DEFIBRILLATORS MARKET FOR HOSPITALS, 20142022 ($MILLION)
Fig. 15 WORLD DEFIBRILLATORS MARKET FOR PREHOSPITAL, 20142022 ($MILLION)
Fig. 16 WORLD DEFIBRILLATORS MARKET FOR PUBLIC ACCESS DEFIBRILLATION, 20142022 ($MILLION)
Fig. 17 WORLD DEFIBRILLATORS MARKET FOR ALTERNATE CARE MARKET, 20142022 ($MILLION)
Fig. 18 WORLD DEFIBRILLATORS MARKET FOR HOME, 20142022 ($MILLION)
Fig. 19 U.S. DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 20 CANADA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 21 MEXICO DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 22 U.K. DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 23 FRANCE DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 24 GERMANY DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 25 ITALY DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 26 SPAIN DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 27 REST OF EUROPE DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 28 JAPAN DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 29 CHINA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 30 INDIA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 31 AUSTRALIA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 32 REST OF ASIA-PACIFIC DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 33 BRAZIL DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 34 ARGENTINA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 35 EGYPT DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 36 ISRAEL DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 37 SOUTH AFRICA DEFIBRILLATORS MARKET, 20142022 ($MILLION)
Fig. 38 ASAHI KASEI CORPORATION: NET REVENUE, 20122014($MILLION)
Fig. 39 ASAHI KASEI CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
Fig. 40 ASAHI KASEI CORPORATION: HEALTHCARE GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 41 ASAHI KASEI CORPORATION: SWOT ANALYSIS
Fig. 42 STRYKER CORPORATION: NET SALES, 20132015 ($MILLION)
Fig. 43 STRYKER CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
Fig. 44 STRYKER CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 45 STRYKER CORPORATION: SWOT ANALYSIS
Fig. 46 BIOTRONIK: SWOT ANALYSIS
Fig. 47 BOSTON SCIENTIFIC CORPORATION: NET SALES, 20132015, ($MILLION)
Fig. 48 BOSTON SCIENTIFIC CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 49 BOSTON SCIENTIFIC CORPORATION: RHYTHM MANAGEMENT REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 50 BOSTON SCIENTIFIC CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 51 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
Fig. 52 PHILIPS: REVENUE, 20132015 ($MILLION)
Fig. 53 PHILIPS: REVENUE, BY SEGMENTS, 2015 (%)
Fig. 54 PHILIPS: HEALTHCARE REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 55 PHILIPS: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 56 PHILIPS HEALTHCARE: SWOT ANALYSIS
Fig. 57 LIVANOVA: NET SALES, 20132015 ($MILLION)
Fig. 58 LIVANOVA: REVENUE, BY BUSINESS SEGMENTS, 2015 (%)
Fig. 59 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 60 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 61 LIVANOVA: SWOT ANALYSIS
Fig. 62 MEDTRONIC: NET SALES, 20132015 ($MILLION)
Fig. 63 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
Fig. 64 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
Fig. 65 MEDTRONIC: SWOT ANALYSIS
Fig. 66 ST. JUDE MEDICAL: NET SALES, 20132015 ($MILLION)
Fig. 67 ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
Fig. 68 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 69 ST. JUDE MEDICAL: SWOT ANALYSIS
Fig. 70 CARDIAC SCIENCE CORPORATION: SWOT ANALYSIS
Fig. 71 NIHON KODEN: REVENUE, 20132015($MILLION)
Fig. 72 NIHON KODEN: REVENUE, BY SEGMENTS, 2015(%)
Fig. 73 NIHON KODEN: REVENUE, BY GEOGRAPHY, 2015(%)
Fig. 74 NIHON KOHDEN: SWOT ANALYSIS
